Product Information
DALIRESP 500 MCG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $14.8147 per EA under NDC 00310009530. Its NADAC has been published 567 times since Aug 19, 2015.
The High Outlier badge above means this manufacturer's average price in the roflumilast market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 ug/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310009530
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROFLUMILASTApproval Type
New Drug (NDA)
FDA Application
NDA022522On Market Since
7/1/2015
Pharmacological Classes
Price Statistics
The NADAC for DALIRESP 500 MCG TABLET has been published 567 times since Aug 19, 2015, and over the history we have for it it has risen 78.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.8147 per EA |
|---|---|
| All-time high | $15.0027 (May 13, 2026) |
| All-time low | $8.3176 (Aug 19, 2015) |
| 52-week high | $15.0027 |
| 52-week low | $14.5429 |
| Median price | $12.6636 |
| Average price | $12.2807 |
| Largest weekly change | +9.0% (Jan 11, 2017) |
| Weeks tracked | 567 |
| Tracking since | Aug 19, 2015 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DALIRESP 500 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DALIRESP 500 MCG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $14.8147 per EA (NDC 00310009530), effective Jun 24, 2026.
How has the price of DALIRESP 500 MCG TABLET changed over time?
Over the history we have for it, the NADAC for DALIRESP 500 MCG TABLET has risen 78.1%. It has been tracked across 567 weekly CMS publications since Aug 19, 2015.
What are the highest and lowest recorded NADAC prices for DALIRESP 500 MCG TABLET?
Since Aug 19, 2015, the NADAC for DALIRESP 500 MCG TABLET has ranged from a low of $8.3176 (Aug 19, 2015) to a high of $15.0027 (May 13, 2026), with a median of $12.6636 per EA.
Are there cheaper alternatives to DALIRESP 500 MCG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ROFLUMILAST 500 MCG TABLET, is $0.3204 per EA — about 98% below DALIRESP 500 MCG TABLET.
Who manufactures DALIRESP 500 MCG TABLET?
DALIRESP 500 MCG TABLET (NDC 00310009530) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.